Literature DB >> 3593840

Termination of pregnancy in mice with antiserum to chicken riboflavin-carrier protein.

U Natraj, A Kumar R, P Kadam.   

Abstract

The importance of riboflavin-carrier protein (RCP) in the maintenance of pregnancy in mice has been studied. Selective passive immunoneutralization of the maternal RCP resulted in fetal death and resorption. Six hours after chicken RCP antiserum treatment, the following observations were made: there was profuse vaginal bleeding in all the animals, a 60% reduction in embryonic ornithine decarboxylase (ODC) activity, a 70% reduction in the maternal progesterone levels, and a 50% reduction in the 14C-riboflavin uptake by the embryo. The above observations are indicative of fetal distress and resorption. By 24 h after treatment, there was 100% resorption of fetuses and the mouse progesterone levels dropped to 20% of untreated or normal rabbit serum (NRS)-treated values. Cytological studies of the fetal liver revealed the classical signs of cellular degeneration in hepatocytes as well as hematopoietic cells. The effect was apparent as early as 1 h after antiserum administration. The erythroid aplasia supports the biochemical evidence that fetal demise is due to preferential riboflavin deficiency of the fetus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3593840     DOI: 10.1095/biolreprod36.3.677

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  5 in total

1.  Crystal structure of chicken riboflavin-binding protein.

Authors:  H L Monaco
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

2.  Characterization of antibodies to chicken riboflavin carrier protein. Immunoneutralizing ability of antibodies to a sequence-specific region of the protein.

Authors:  U Natraj; S George; M S Kadam
Journal:  Biochem J       Date:  1988-08-15       Impact factor: 3.857

Review 3.  Genetic control of biosynthesis and transport of riboflavin and flavin nucleotides and construction of robust biotechnological producers.

Authors:  Charles A Abbas; Andriy A Sibirny
Journal:  Microbiol Mol Biol Rev       Date:  2011-06       Impact factor: 11.056

Review 4.  Riboflavin-Targeted Drug Delivery.

Authors:  Milita Darguzyte; Natascha Drude; Twan Lammers; Fabian Kiessling
Journal:  Cancers (Basel)       Date:  2020-01-27       Impact factor: 6.639

Review 5.  Riboflavin Deficiency-Implications for General Human Health and Inborn Errors of Metabolism.

Authors:  Signe Mosegaard; Graziana Dipace; Peter Bross; Jasper Carlsen; Niels Gregersen; Rikke Katrine Jentoft Olsen
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.